Stay up to date with our latest products, technologies and company news, and meet our teams at upcoming events. We also share insights from consumer testing, scientific data and market trends across a broad range of application areas.
Four new patents open new doors to innovative and precise oral delivery of cannabinoids in the US and Canadian markets. The patents granted to NordicCan cover novel gum base formulations improving oral delivery of cannabinoids. The worldwide interest in...
In this interview with Julie Malbaek, CEO of NordicCan, we explore the expanding and evolving market for cannabinoids. Julie explains, among others, how and why the ultimate breakthrough for cannabinoids, especially CBD, is getting closer. While restrictions, substance-scheduling and...
Vejle, 1 July, 2021 EQT announced today that it has agreed to sell Fertin Pharma, a specialist contract development and manufacturing organization (CDMO) in innovative oral and intra-oral delivery technologies, to Philip Morris International (PMI) (NYSE: PM). With headquarters...
NordicCan, a full Contract Development and Manufacturing Organisation specialized in innovative cannabinoid solutions for the B2B market, announced that the Canadian Intellectual Property Office has issued patent numbers CA 3,031,530 and CA 3,035,400 covering the use of cannabinoids within...
VEJLE, Denmark—March 7, 2021—NordicCan, a full Contract Development and Manufacturing Organisation specialized in innovative cannabinoid solutions for the B2B market, has obtained approval a Research License from Health Canada under the Cannabis Act. The Research License is a key...
VEJLE, Denmark—March 5, 2021—NordicCan, a full Contract Development and Manufacturing Organisation specialized in innovative cannabinoid solutions for the B2B market, today announced that the United States Patent and Trademark Office (USPTO) has issued it two patents: U.S. Patent No....
Full Contract Development and Manufacturing Organization will continue to specialize in innovative cannabinoid solutions for the B2B market MedCan Pharma A/S announced today the launch of a new corporate name and brand identity. The organization will now be known...